# OnCo record nct07372625 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07372625/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07372625", "NCT07372625" ;
  schema:name "A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation."@en ;
  schema:description "A phase 1 trial of Rezatapopt run by PMV Pharmaceuticals, Inc, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07372625/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07372625> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:drugs <https://onco.cc/drugs/rezatapopt/> ;
  onco:companies <https://onco.cc/companies/pmv-pharma/> .